Correction: Activation of RAS/MAPK pathway confers MCL-1 mediated acquired resistance to BCL-2 inhibitor venetoclax in acute myeloid leukemia
Saved in:
Published in | Signal transduction and targeted therapy Vol. 7; no. 1; p. 110 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
Nature Publishing Group UK
01.04.2022
Nature Publishing Group |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Bibliography: | correction SourceType-Other Sources-1 content type line 63 ObjectType-Correction/Retraction-1 |
---|---|
ISSN: | 2059-3635 2095-9907 2059-3635 |
DOI: | 10.1038/s41392-022-00958-4 |